Medifast, Inc.

NYSE:MED

Personal Products & Services

Consumer Cyclical
$12.20 -0.04%

-$0.01 today

Market cap
$136.43M
Beta
0.66
P/E (TTM)
-6.2
EPS (TTM)
-$1.82
52W Low $9.22High $15.46

Volume 0.09M

Average 0.21M

MED Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Medifast, Inc.NYSE: MED

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue declines year over year

Q1 FY2026 revenue of $76.04M fell 34.3% year over year, ahead of the -36.3% change in trailing-twelve-month revenue. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at -37.7% a year.

Context

  • Revenue increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of $288.5M (-25.2%) for the fiscal year ending Dec 2026, a step up from the -36.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$76.04M+1.3% QoQ
Last fiscal yearDec 2025
$385.79M-36.0% YoY
LTMMar 2026
$346.1M-36.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-34.3%-31.1%+3.2 pp
1 year-36.0%-25.2%+10.7 pp
3-year CAGR-37.7%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
385.79M USD
Year-over-year change
-36.0%
4-year CAGR
-29.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How MED compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -36.3% is the 9th highest of 10, against a peer median of +0.8%.
  • Over three fiscal years its annual growth of -37.7% compares with a peer median of -1.6%.
MED Competitors
Revenue for MED and competitors
Company Period LTM YoY 3-year CAGR
CURVTorrid Holdings Inc.LTM May 2026$979.93M USD-10.1%-8.1%
CAASChina Automotive Systems, Inc.LTM Dec 2025$765.74M USD+17.6%+13.1%
AKAa.k.a. Brands Holding Corp.LTM Mar 2026$604.02M USD+3.0%-0.6%
MBMasterBeef GroupFY2025HK$459.1M HKD-8.9%+0.2%
MEDMedifast, Inc.LTM Mar 2026$346.1M USD-36.3%-37.7%
BSETBassett Furniture Industries, IncorporatedLTM Feb 2026$333.46M USD+2.4%-11.6%
KEQUKewaunee Scientific CorporationLTM Jan 2026$287.75M USD+30.8%+12.5%
CLARClarus CorporationLTM Mar 2026$252.46M USD-1.2%-7.4%
DIBS1stdibs.Com, Inc.LTM Mar 2026$89.46M USD+0.8%-2.6%
AIIORobo.ai Inc.FY2025$950K USD-92.1%—
Peer median (excluding MED) —+0.8%-1.6%

Competitors are the stored peer set for MED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.53B1.6B1.07B602.46M385.79M
Cost of Revenue398.49M458.16M296.2M157.84M110.6M
Gross Profit1.13B1.14B775.85M444.62M275.19M
Gross Margin73.9%71.3%72.4%73.8%71.3%
Research & Development00000
Selling, General & Admin911.36M955.61M649.45M441.75M289.4M
Operating Expenses911.36M955.61M649.45M441.75M289.4M
Depreciation & Amortization6.81M10.98M13.11M12.71M10.5M
EBITDA222.94M195.74M141.9M16.49M4.86M
EBITDA Margin14.6%12.2%13.2%2.7%1.3%
Operating Income216.24M184.81M126.4M2.88M(14.21M)
Operating Margin14.2%11.6%11.8%0.5%-3.7%
Interest Income002.49M4.8M5.52M
Interest Expense231K701K000
Other Income / Expenses(112K)(747K)2.4M909K8.57M
Income Before Tax216.13M184.06M128.8M3.79M(5.64M)
Pre-Tax Margin14.2%11.5%12.0%0.6%-1.5%
Income Tax Expense52.1M40.49M29.38M1.7M13.03M
Net Income164.03M143.57M99.42M2.09M(18.67M)
Net Margin10.7%9.0%9.3%0.3%-4.8%
EPS (Basic)14.0112.829.100.19(1.70)
EPS (Diluted)13.8912.739.100.19(1.70)
Weighted Avg Shares11.71M11.2M10.88M10.93M10.98M
Weighted Avg Shares (Diluted)11.81M11.28M10.92M10.96M10.98M

Medifast, Inc.

NYSE:MED

Intrinsic Alpha fair value

Locked

Current Price

$12.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.